Selfie on the BioJapan 2025 exhibition floor: attendee in foreground, crowded aisles with posters and company booths, “AIST” jacket visible, signage directing to partnering zones.
The surge I sensed at BioJapan 2025 in October reflects deliberate engineering rather than hype: targeted […]
Abstract landscape of sand-toned islands linked by light-blue channels, with dark-blue bio-factory shapes and red markers suggesting biologics flow across Japanese hubs.
A New Order is taking shape in Japan’s life sciences. Conference floors are packed, university benches […]
Two executives in a golden-yellow meeting room lean over a large sheet of paper spread across the table. They are animatedly pointing and gesturing, immersed in discussion, as if the printed spreadsheet in front of them holds the key to their success in Japan’s pharma market.
An A3 Executive Reference (2 pages) Japan rewards programs that are sequenced, evidenced, and locally socialized. […]
Two smiling businesswomen in an office with a view of Tokyo, collaborating on a whiteboard with flowcharts and a large corkboard filled with colorful sticky notes.
Cracking Japan’s Pharma Ecosystem: Field Notes from ~20 Years in the Trenches Japan rewards sequencing, proof, […]
Abstract representation of Moderna's diversified mRNA pipeline targeting Japan’s infectious and rare diseases.
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]
Illustration showing Japan's pharmaceutical market decline with red arrow, pills, and bar graph.
In the mid-1990s, Japan was not merely participating in the global pharmaceutical industry—it was shaping it. […]
  Just now, AstraZeneca is making headlines with a $5.3 billion AI research partnership with China’s […]
: A bustling exhibition displaying the latest in IVD technology at the JACLaS Tradeshow. An official JACKLaS image.
Just before BioJapan 2025 takes over Pacifico Yokohama (Oct 8–10), another major event for diagnostics, JACLaS […]
Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Abstract illustration representing Japan’s SaMD commercialization ecosystem.
Japan is the fourth-largest global medical device market, with its healthcare system actively integrating digital tools […]